NCT00093119View on ClinicalTrials.gov

Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

February 28, 2005

Conditions
MelanomaMetastases
Interventions
DRUG

ABI-007

Trial Locations (1)

27703

Abraxis BioScience Inc., Durham

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY